menu search

Biohaven drug is a long shot, but success could boost shares

Biohaven pharmaceutical Holding Company Ltd. ( BHVN , Financial) and its shareholders could be in for a...

March 22, 2022, 10:17 am

Terns reports topline results from early-stage nash study

Terns pharmaceuticals Inc (NASDAQ: TERN) reported topline results from Part 1 of Phase 1b AVIATION T...

March 22, 2022, 9:33 am

Why oric pharmaceuticals shares are plunging today

ORIC pharmaceuticals Inc (NASDAQ: ORIC) has decided to discontinue the further development of ORIC-10...

March 22, 2022, 9:33 am

Synaptogenix to present at sachs 5th annual neuroscience innovation forum

NEW YORK , March 22, 2022 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging bio...

March 22, 2022, 9:15 am

Infinity pharmaceuticals announces the date of its fourth quarter and full year 2021 financial results conference call and webcast

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biot...

March 22, 2022, 7:35 am

Novabay pharmaceuticals to hold 2021 fourth quarter and full year conference call on march 29

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® pharmaceuticals, Inc. (NYSE American: NBY) announces tha...

March 22, 2022, 6:50 am

Sage therapeutics to present at 2022 stifel cns days

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company ...

March 22, 2022, 6:30 am

Oric pharmaceuticals, inc.'s (oric) ceo jacob chacko on q4 2021 results - earnings call transcript

ORIC pharmaceuticals, Inc.'s (ORIC) CEO Jacob Chacko on Q4 2021 Results - Earnings Call Transcript...

March 21, 2022, 8:48 pm

Rigel pharmaceuticals: why the stock is on a run

RIGL announced Q4'21 earnings in early March leading the stock to rally over 20%....

March 21, 2022, 5:35 pm

Marinus pharmaceuticals, inc. (mrns) ceo dr. scott braunstein on q4 2021 results - earnings call transcript

Marinus pharmaceuticals, Inc. (MRNS) CEO Dr. Scott Braunstein on Q4 2021 Results - Earnings Call Transc...

March 21, 2022, 1:43 pm

Atai life sciences to participate in upcoming march investor conferences

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage bio...

March 21, 2022, 1:08 pm

Tonix says fibromyalgia candidate failed to achieve statistical significance over placebo

Tonix pharmaceuticals Holding Corp (NASDAQ: TNXP) says that as expected, TNX-102 SL (cyclobenzaprine H...

March 21, 2022, 10:20 am

2 top biotech stocks to buy right now

The global pharmaceutical industry grows in importance with each passing year. These two companies are ...

March 21, 2022, 10:00 am

Why are allena pharma shares plunging today

An independent data safety monitoring board (DSMB) has conducted the first of two planned Sample Size Reestimations (SSR1) of Phase 3 URIROX-2 Trial�...

March 21, 2022, 9:48 am

Avadel pharmaceuticals plc: initiating buy, bye bye to sleepiness

We are initiating AVDL at a speculative buy rating, with a target price of USD 14....

March 21, 2022, 9:46 am

Painreform to present at the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest on march 28th - 30th

TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty ...

March 21, 2022, 9:25 am

Wellbeing digital sciences says its kgk science subsidiary engaged by lophos pharmaceuticals for novel peyote study

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc announced that its wholly-owned subsidiary, KGK Science Inc has been engaged by Lophos ...

March 21, 2022, 8:26 am

Ionis to present at upcoming investor conferences

CARLSBAD, Calif. , March 21, 2022 /PRNewswire/ -- Ionis pharmaceuticals, Inc. (Nasdaq: IONS) today anno...

March 21, 2022, 7:05 am

Pardes biosciences to present at the international conference on antiviral research 2022

CARLSBAD, Calif. , March 21, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage bio...

March 21, 2022, 7:00 am

Shield therapeutics partner submits iron deficiency drug for approval in canada

Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) said partner KYE pharmaceuticals Inc has made a new drug...

March 21, 2022, 3:22 am


Search within

Pages Search Results: